Fresenius Medical Care’s (FMS) Buy Rating Reaffirmed at DZ Bank
Other equities research analysts also recently issued reports about the company. Morgan Stanley downgraded Fresenius Medical Care from an overweight rating to an equal weight rating in a research report on Monday, December 11th. Royal Bank of Canada reiterated a hold rating and issued a $44.00 price target on shares of Fresenius Medical Care in a report on Wednesday, September 13th. Finally, Zacks Investment Research upgraded Fresenius Medical Care from a sell rating to a hold rating and set a $53.00 price target on the stock in a report on Monday, October 9th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of Hold and an average price target of $48.50.
Shares of Fresenius Medical Care (NYSE FMS) opened at $52.15 on Monday. Fresenius Medical Care has a 52-week low of $39.46 and a 52-week high of $52.41. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.98 and a current ratio of 1.22. The stock has a market capitalization of $31,594.93, a P/E ratio of 23.07, a price-to-earnings-growth ratio of 2.31 and a beta of 0.45.
TRADEMARK VIOLATION WARNING: This article was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The correct version of this article can be accessed at https://www.watchlistnews.com/fresenius-medical-cares-fms-buy-rating-reaffirmed-at-dz-bank/1772837.html.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.